Literature DB >> 1462760

Clarke's column in sporadic amyotrophic lateral sclerosis.

H Takahashi1, K Oyanagi, E Ohama, F Ikuta.   

Abstract

Histological, ultrastructural and morphometrical observations on Clarke's column were carried out in 18 patients with sporadic amyotrophic lateral sclerosis (ALS) and 15 age-matched control subjects. Of the 18 ALS patients 6 had been on a respirator before death. Bunina bodies were found in the neuronal cytoplasm in 7 of the 12 non-respirator-supported ALS patients and in 3 of the 6 respirator-supported patients. The number of spheroids was significantly higher in the non-respirator-supported patients (P < 0.01) than in the control subjects; however, the number in the respirator-supported patients was about equal to that in the controls. The number of neurons in Clarke's column in the non-respirator-supported ALS patients was not reduced, but in the respirator-supported patients they tended to disappear with time after respiratory support. These findings suggest that Clarke's column neurons are also involved primarily in the disease process in sporadic ALS. However, they may begin to disappear only after the patients require respiratory support.

Entities:  

Mesh:

Year:  1992        PMID: 1462760     DOI: 10.1007/bf00304464

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  14 in total

1.  Evidence for sequential degeneration of the neurons in the intermediate zone of the spinal cord in amyotrophic lateral sclerosis: a topographic and quantitative investigation.

Authors:  K Oyanagi; F Ikuta; Y Horikawa
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Amyotrophic lateral sclerosis: oculomotor function in patients in respirators.

Authors:  H Hayashi; S Kato; T Kawada; T Tsubaki
Journal:  Neurology       Date:  1987-08       Impact factor: 9.910

3.  [Pathology of Clarke's nucleus in sporadic amyotrophic lateral sclerosis].

Authors:  K Okamoto; T Yamazaki; H Yamaguchi; M Shooji; S Hirai
Journal:  Rinsho Shinkeigaku       Date:  1988-05

4.  Proximal axonal enlargement in motor neuron disease.

Authors:  S Carpenter
Journal:  Neurology       Date:  1968-09       Impact factor: 9.910

5.  A method for ultrastructural study of lesions found in conventional histological sections.

Authors:  G L Rossi; H Luginbühl; D Probst
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1970

6.  Regular involvement of Clarke's nucleus in sporadic amyotrophic lateral sclerosis.

Authors:  P Averback; P Crocker
Journal:  Arch Neurol       Date:  1982-03

7.  Ultrastructure of the Bunina bodies in anterior horn cells of amyotrophic lateral sclerosis.

Authors:  M Tomonaga; M Saito; M Yoshimura; H Shimada; H Tohgi
Journal:  Acta Neuropathol       Date:  1978-05-24       Impact factor: 17.088

8.  Total manifestations of amyotrophic lateral sclerosis. ALS in the totally locked-in state.

Authors:  H Hayashi; S Kato
Journal:  J Neurol Sci       Date:  1989-10       Impact factor: 3.181

9.  Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management.

Authors:  R Tandan; W G Bradley
Journal:  Ann Neurol       Date:  1985-09       Impact factor: 10.422

10.  Swellings of proximal axons in a case of motor neuron disease.

Authors:  S Sasaki; S Maruyama; K Yamane; H Sakuma; M Takeishi
Journal:  Ann Neurol       Date:  1989-05       Impact factor: 10.422

View more
  3 in total

1.  Spinocerebellar ataxia type 6 with motor neuron loss: a follow-up autopsy report.

Authors:  Shinji Ohara; Teruaki Iwahashi; Takashi Oide; Ryoichi Hayashi; Takashi Nakajima; Kinya Ishikawa; Hidehiro Mizusawa
Journal:  J Neurol       Date:  2002-05       Impact factor: 4.849

2.  The intermediolateral nucleus in sporadic amyotrophic lateral sclerosis.

Authors:  H Takahashi; K Oyanagi; F Ikuta
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  Age-Related Uptake of Heavy Metals in Human Spinal Interneurons.

Authors:  Roger Pamphlett; Stephen Kum Jew
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.